References
1. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140: 900-17.
2. Bezredka A.M. On the importance of irritants in infection and immunity. Zhurnal eksperimental’noy i klinicheskoy meditsiny. 1927; 7 (18): 265-70. (in Russian)
3. Kozlov I.G. Microbiota, mucosal immunity and antibiotics: the fineness of the interaction. RMZh. 2018; 8 (I): 19-27. (in Russian)
4. Du X., Poltorak A., Wei Y., Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 2000; 11: 362-71.
5. Girardin S.E., Travassos L.H., Herve M., et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 2003; 278: 41 702-8.
6. Lemaire B., Nicolas E., Michaut L., et al. The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996; 86: 973-83.
7. Medzhitov R., Janeway C. Innate Immunity. N. Engl. J. Med. 2000; 343: 338-44.
8. Yoneyama M., FujitaT. Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem. 2007; 282: 15 315-8.
9. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001.; 2: 675-80.
10. Foster S.L., Hargreaves D.C, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modification. Nature. 2007; 447: 972-8.
11. Kim H.J., Kim C.H., Kim M.J., Ryu J.H., et al. The induction of pattern-recognition receptor expression against influenza A virus through Duox2-derived reactive oxygen species in nasal mucosa. Am. J. Respir. Cell Mol. Biol. 2015; 53: 525-35.
12. Medzhitov R. Toll-like receptors and innate immunity. Nat. Immunol. 2001; 1: 135-45.
13. Qiu H.N., Wong C.K., Chu I.M., Hu S., et al. Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation. Clin. Exp. Immunol. 2013; 172: 81-94.
14. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 1974; 59: 1317-25.
15. Lederer E. New developments in the field of synthetic mur-amyl peptides, especially as adjuvants for synthetic vaccines. Drugs Exp. Clin. Res. 1986; 12 (6-7): 429-40.
16. Ivanov V.T., Khaitov R.M., Andronova T.M. Pinegin B.V. Likopid (glucosaminylmuramyl dipeptide) is a new domestic highly effective immunomodulator for the treatment and prevention of diseases associated with secondary immunological deficiency. Immu-nologiya. 1996; 2: 4-6. (in Russian)
17. Pinegin B.V., Andronova T.M. Some theoretical and practical issues of the clinical use of the immunomodulator lycopid. Immu-nologiya. 1998; 18: 60-3. (in Russian)
18. Pinegin B.V., Pashchenkov M.V. Muramyl peptide im-munomodulators in the treatment and prevention of infectious and inflammatory processes. Immunologiya. 2019; 40: 75-80. (in Russian)
19. Mijosek V., Lasitschka F., Warth A., Zabeck H., et al. Endoplasmic reticulum stress is a danger signal promoting innate inflammatory responses in bronchial epithelial cells. J. Innate Immun. 2016; 8 (5): 464-78.
20. Strober W., Murray P., Kitani A., et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006; (6): 9-20. https://doi.org/10.1038/nri1747
21. Kiryukhin A.V., Parfyonova N.A., Maksimova T.A., et al. Optimization of treatment for frequently and long-term ill children: immunocorrection with Lycopidum. In: Lycopid in the complex treatment and prevention of immunodeficiency states. Moscow, 2005: 57-64. (in Russian)
22. Coulombe F., Fiola S., Akira S., Cormier Y., et al. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One. 2012; 7 (5): e36734.
23. Anderson P.M. Immune therapy for sarcomas. Adv. Exp. Med. Biol. 2017; 995: 127-40.
24. Kozlov I.G., Voronina E.V., Valyakina T.I., Simonova M.A., et al. Licopid in immunotherapy of tumors: Review of experimental research (review of literature). Voprosy gematologii/onkologii i im-munopatologii v pediatrii. 2011; 10 (2): 32-8. (in Russian)
25. Andriyanova I.E., Filimonova G.I., Andronova T.M. The effect of the immunomodulator glucosaminyl muramyl dipeptide on hematopoiesis of mice with experimental cytopenia. Radiobiology. 1992; 32 (4): 566-70. (in Russian)
26. Manapova E.R., Fazylov V.Ch., Guryanova S.V. Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1. Voprosy virusologii. 2017; 62 (4): 174-8. (in Russian)